GB0004530D0 - Adjuvants - Google Patents

Adjuvants

Info

Publication number
GB0004530D0
GB0004530D0 GBGB0004530.2A GB0004530A GB0004530D0 GB 0004530 D0 GB0004530 D0 GB 0004530D0 GB 0004530 A GB0004530 A GB 0004530A GB 0004530 D0 GB0004530 D0 GB 0004530D0
Authority
GB
United Kingdom
Prior art keywords
adjuvants
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0004530.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nottingham
Original Assignee
University of Nottingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nottingham filed Critical University of Nottingham
Priority to GBGB0004530.2A priority Critical patent/GB0004530D0/en
Publication of GB0004530D0 publication Critical patent/GB0004530D0/en
Priority to PCT/GB2001/000816 priority patent/WO2001062282A2/en
Priority to AU33971/01A priority patent/AU3397101A/en
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB0004530.2A 2000-02-25 2000-02-25 Adjuvants Ceased GB0004530D0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
GBGB0004530.2A GB0004530D0 (en) 2000-02-25 2000-02-25 Adjuvants
PCT/GB2001/000816 WO2001062282A2 (en) 2000-02-25 2001-02-26 Adjuvants for vaccines
AU33971/01A AU3397101A (en) 2000-02-25 2001-02-26 Adjuvants

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0004530.2A GB0004530D0 (en) 2000-02-25 2000-02-25 Adjuvants

Publications (1)

Publication Number Publication Date
GB0004530D0 true GB0004530D0 (en) 2000-04-19

Family

ID=9886439

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0004530.2A Ceased GB0004530D0 (en) 2000-02-25 2000-02-25 Adjuvants

Country Status (3)

Country Link
AU (1) AU3397101A (en)
GB (1) GB0004530D0 (en)
WO (1) WO2001062282A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100879810B1 (en) 2000-02-21 2009-01-22 하. 룬드벡 아크티에셀스카브 Novel method for down-regulation of amyloid
MY144532A (en) 2001-08-20 2011-09-30 Lundbeck & Co As H Novel method for down-regulation of amyloid

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2166289A1 (en) * 1993-07-02 1995-01-12 Barrie Walsham Bycroft Immunosuppressant and antiallergic compounds e.g. n-(3-oxohexanoyl) homoserine lactone

Also Published As

Publication number Publication date
AU3397101A (en) 2001-09-03
WO2001062282A3 (en) 2001-12-27
WO2001062282A2 (en) 2001-08-30

Similar Documents

Publication Publication Date Title
GB0020953D0 (en) Vaccine
HUP0301092A3 (en) Vaccine
IL155072A0 (en) Vaccine
AU3391801A (en) Pyridinylimidazoles
AU1591402A (en) Vaccine
GB0014288D0 (en) Vaccine
AU4871001A (en) Lipopeptide adjuvants
AU4686401A (en) Hypotensors
GB0014845D0 (en) Vaccine
GB0026334D0 (en) Vaccine
AU4831301A (en) Gm-negative ehv-mutants
GB0025694D0 (en) Vaccine
GB0004530D0 (en) Adjuvants
GB0003082D0 (en) Vaccine
GB0028423D0 (en) Eductional aid
GB0006693D0 (en) Vaccine
GB0015722D0 (en) Vaccine
GB0015935D0 (en) Vaccine
GB0028494D0 (en) Tassel-making aid
AU1702P (en) Trailblazer Xanthostemon chrysanthus
AU1852P (en) Tickit xTriticosecale
AU2117P (en) Gauka Gaura lindheimeri
GB9904283D0 (en) Adjuvants
GB0018602D0 (en) Vaccine
GB0025573D0 (en) Vaccine

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)